Calendar BioArctic AB

Equities

BIOA B

SE0010323311

Market Closed - Nasdaq Stockholm 17:00:00 19/07/2024 BST 5-day change 1st Jan Change
225.6 SEK -2.25% Intraday chart for BioArctic AB -4.73% -15.76%

Chart calendar BioArctic AB

2580.w0bEc4eG606tlob4Vlb8H_edq6QCKn0-xlor0G7LYmg.kw-RR7bPqBqerrS2BBeNcIfU0ulIWDJxvDFOg1-EUAWoHvchw9CICcflyw~3ff3cf9e2dc977ecc42d2c50efd402a8

Upcoming events on BioArctic AB

29/08/2024 07:00 Q2 2024 Earnings Release
14/11/2024 07:00 Q3 2024 Earnings Release
13/02/2025 07:00 Q4 2024 Earnings Release
23/04/2025 Q1 2025 Earnings Release (Projected)
09/07/2025 Q2 2025 Earnings Release (Projected)
15/10/2025 Q3 2025 Earnings Release (Projected)
11/02/2026 Q4 2025 Earnings Release (Projected)

Past events on BioArctic AB

22/05/2024 15:30 Annual General Meeting
17/05/2024 08:30 Q1 2024 Earnings Call
17/05/2024 07:00 Q1 2024 Earnings Release
09/03/2024 09:25 Alzheimer and Parkinson Diseases International Conference - Structural dynamics of amyloid-? protofi
09/03/2024 09:10 Alzheimer and Parkinson Diseases International Conference - Lecanemab for the treatment of early Alz
09/03/2024 08:40 Alzheimer and Parkinson Diseases International Conference - Binding characteristics of lecanemab, do
07/03/2024 Alzheimer and Parkinson Diseases International Conference - Presentation : P0111 / #943
07/03/2024 Alzheimer and Parkinson Diseases International Conference - Presentation P0110 / #562
07/03/2024 Alzheimer and Parkinson Diseases International Conference - Presentation P0213 / #1510
07/03/2024 15:20 Alzheimer and Parkinson Diseases International Conference - Novel approaches to clinical development
07/03/2024 13:50 Alzheimer and Parkinson Diseases International Conference - Treatment with lecanemab disrupts tau ac
07/03/2024 11:10 Alzheimer and Parkinson Diseases International Conference - Defining meaningful benefits to patients
04/03/2024 Alzheimer and Parkinson Diseases International Conference
14/02/2024 08:30 Q4 2023 Earnings Call
14/02/2024 07:00 Q4 2023 Earnings Release
06/02/2024 04:08 Q4 2023 Sales and Revenue Release
08/11/2023 08:30 Q3 2023 Earnings Call
08/11/2023 07:00 Q3 2023 Earnings Release
07/11/2023 04:16 Q3 2023 Sales and Revenue Release
26/10/2023 19:50 Clinical Trials on Alzheimer Disease Conference

Past dividends on BioArctic AB

09/05/2019 Annual 1.5 SEK

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK
Released
Forecast
Spread
282
294
-4.07%
65,9
57,6
14.46%
23,1
121
-80.83%
230
220
4.71%
616
559
10.2%

512

EBITDA
Million SEK
Released
Forecast
Spread
122
71,6
70.05%
-74,0
-152
51.22%
-127
-60,2
-110.39%
-2,81
-10,5
73.25%
271
277
-2.06%

-50,0

EBIT
Million SEK
Released
Forecast
Spread
113
72,3
55.54%
-85,0
-151
43.69%
-140
-59,5
-134.88%
-17,4
-78,1
77.68%
253
264
-4.42%

3,77

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
113
72,2
56.52%
-86,7
-152
42.92%
-141
-60,3
-132.92%
-11,2
-34,1
67.22%
276
209
32.35%

19,1

Net income
Million SEK
Released
Forecast
Spread
88,5
56,4
57.03%
-68,5
-142
51.78%
-120
-60,3
-98.66%
-11,2
-64,6
82.7%
229
183
25.1%

2,85

EPS
SEK
Released
Forecast
Spread
1,00
0,64
56.25%
-0,78
-1,31
40.63%
-1,36
-0,68
-99.12%
-0,13
-0,72
81.84%
2,59
2,09
24.22%

0,02

Announcement Date06/02/2004/02/2103/02/2203/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million SEK
Released
Forecast
Spread






2,75
3,00
-8.47%
209
119
75.49%
11,0
15,9
-30.67%
29,6
18,2
62.81%

49,6


357


108


147

EBIT
Million SEK
Released
Forecast
Spread






-101
-94,0
-7.31%
131
23,0
469.62%
-78,1
-67,8
-15.19%
-73,1
-81,8
10.59%

-79,9


218


-50,7


13,8

Net income
Million SEK
Released
Forecast
Spread
-44,3


294


























EPS
SEK
Released
Forecast
Spread
-0,50


3,31


-1,16
-0,98
-18.37%
1,41
2,00
-29.5%
-0,99
-0,90
-10%
-0,65
-0,80
18.75%

-0,90


2,40


-0,60


0,30

Announcement Date28/04/2227/04/2312/07/2308/11/2314/02/2417/05/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise